Pharmosa Biopharm Statistics
Total Valuation
TPEX:6875 has a market cap or net worth of TWD 6.74 billion. The enterprise value is 5.24 billion.
Market Cap | 6.74B |
Enterprise Value | 5.24B |
Important Dates
The next estimated earnings date is Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:6875 has 129.09 million shares outstanding. The number of shares has increased by 11.49% in one year.
Current Share Class | n/a |
Shares Outstanding | 129.09M |
Shares Change (YoY) | +11.49% |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | 8.54% |
Owned by Institutions (%) | 3.03% |
Float | 76.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 39.38 |
PB Ratio | 3.48 |
P/TBV Ratio | 3.48 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -31.43 |
EV / Sales | 31.26 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -17.91 |
Financial Position
The company has a current ratio of 14.48, with a Debt / Equity ratio of 0.06.
Current Ratio | 14.48 |
Quick Ratio | 14.03 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | -0.40 |
Interest Coverage | -90.35 |
Financial Efficiency
Return on equity (ROE) is -10.84% and return on invested capital (ROIC) is -8.19%.
Return on Equity (ROE) | -10.84% |
Return on Assets (ROA) | -7.81% |
Return on Invested Capital (ROIC) | -8.19% |
Return on Capital Employed (ROCE) | -10.67% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.10 |
Inventory Turnover | 1.74 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.93% in the last 52 weeks. The beta is 0.58, so TPEX:6875's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | -39.93% |
50-Day Moving Average | 55.57 |
200-Day Moving Average | 59.99 |
Relative Strength Index (RSI) | 44.33 |
Average Volume (20 Days) | 81,427 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6875 had revenue of TWD 167.57 million and -166.65 million in losses. Loss per share was -1.32.
Revenue | 167.57M |
Gross Profit | 126.90M |
Operating Income | -218.57M |
Pretax Income | -166.65M |
Net Income | -166.65M |
EBITDA | -205.09M |
EBIT | -218.57M |
Loss Per Share | -1.32 |
Balance Sheet
The company has 1.62 billion in cash and 117.60 million in debt, giving a net cash position of 1.50 billion or 11.63 per share.
Cash & Cash Equivalents | 1.62B |
Total Debt | 117.60M |
Net Cash | 1.50B |
Net Cash Per Share | 11.63 |
Equity (Book Value) | 1.94B |
Book Value Per Share | 15.01 |
Working Capital | 1.57B |
Cash Flow
In the last 12 months, operating cash flow was -127.16 million and capital expenditures -165.27 million, giving a free cash flow of -292.43 million.
Operating Cash Flow | -127.16M |
Capital Expenditures | -165.27M |
Free Cash Flow | -292.43M |
FCF Per Share | -2.27 |
Margins
Gross margin is 75.73%, with operating and profit margins of -130.43% and -99.45%.
Gross Margin | 75.73% |
Operating Margin | -130.43% |
Pretax Margin | -99.45% |
Profit Margin | -99.45% |
EBITDA Margin | -122.39% |
EBIT Margin | -130.43% |
FCF Margin | n/a |
Dividends & Yields
TPEX:6875 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -11.49% |
Shareholder Yield | -11.49% |
Earnings Yield | -2.47% |
FCF Yield | -4.34% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TPEX:6875 has an Altman Z-Score of 24.28.
Altman Z-Score | 24.28 |
Piotroski F-Score | n/a |